223 related articles for article (PubMed ID: 17061060)
1. Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats.
Kamocka M; Kaplinska K; Mielicki WP
Clin Exp Med; 2006 Oct; 6(3):119-23. PubMed ID: 17061060
[TBL] [Abstract][Full Text] [Related]
2. Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro.
Kamocka M; Rózalski M; Krajewska U; Wierzbicki R; Mielicki WP
Cancer Lett; 2005 May; 222(1):89-94. PubMed ID: 15837545
[TBL] [Abstract][Full Text] [Related]
3. Morphologic aspect of the placenta in young and adult pregnant rats bearing Walker 256 carcinoma.
Toledo MT; Gomes-Marcondes MC
Oncol Res; 1999; 11(8):359-66. PubMed ID: 10803739
[TBL] [Abstract][Full Text] [Related]
4. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
[TBL] [Abstract][Full Text] [Related]
5. [Effects of electroacupuncture on tumor growth and immune function in the Walker-256 model rat].
Lai M; Wang SM; Zhang WL; Wang Y; Huang SQ; Dong W; Li A
Zhongguo Zhen Jiu; 2008 Aug; 28(8):607-9. PubMed ID: 18767588
[TBL] [Abstract][Full Text] [Related]
6. Placental glycogen metabolism changes during walker tumour growth.
Toledo MT; Gomes Marcondes MC
Placenta; 2004 May; 25(5):456-62. PubMed ID: 15081640
[TBL] [Abstract][Full Text] [Related]
7. [Effect of whole-body controlled hyperthermia on lipid peroxidation products and lysosomal enzyme levels in blood serum from Wistar rats with Walker-256 carcinosarcoma].
Pupyshev AB; Fedina RG; Michurina SV; Ovsianko EV; Efremov AV
Vopr Onkol; 2009; 55(2):221-3. PubMed ID: 19514380
[TBL] [Abstract][Full Text] [Related]
8. [The effect of immunization with antigens from heterologous and autologous liver on metastasis of Walker carcinosarcoma in parabiontic rats].
Maĭskiĭ IN; Khundanov LL
Biull Eksp Biol Med; 1967 Jun; 63(6):94-6. PubMed ID: 5622622
[No Abstract] [Full Text] [Related]
9. [The effect of autotransfusion of photo-modified blood on the growth of Walker's carcinosarcoma].
Chalenko VV; Zhilkina SV; Rakovshchik DG; Medvedev AN
Vopr Onkol; 1991; 37(7-8):830-4. PubMed ID: 1842637
[TBL] [Abstract][Full Text] [Related]
10. Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.
Gordon SG; Mielicki WP
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):73-86. PubMed ID: 9518049
[TBL] [Abstract][Full Text] [Related]
11. Cancer procoagulant in human tumor cells: evidence from melanoma patients.
Donati MB; Gambacorti-Passerini C; Casali B; Falanga A; Vannotti P; Fossati G; Semeraro N; Gordon SG
Cancer Res; 1986 Dec; 46(12 Pt 1):6471-4. PubMed ID: 3536081
[TBL] [Abstract][Full Text] [Related]
12. Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
Kaplinska K; Rozalski M; Krajewska U; Mielicki WP
Thromb Res; 2009 Jul; 124(3):364-7. PubMed ID: 19419757
[TBL] [Abstract][Full Text] [Related]
13. [The growth dynamics of Walker carcinosarcoma during exposure to a magnetic eddy field].
Bakhmutskiĭ NG; Pylëva TA; Frolov VE; Ripa IM
Vopr Onkol; 1991; 37(6):705-8. PubMed ID: 1843148
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility of establishment of rat model of bone cancer pain by using Walker 256 cells cultured in vitro or in vivo].
Yao M; Yang JP; Wang LN; Cheng H; Zhang YB; Xu QN; Wu YW
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(13):880-4. PubMed ID: 18756951
[TBL] [Abstract][Full Text] [Related]
15. [The effect of ferromagnet particles on the growth of Walker carcinosarcoma 256 in Wistar rats].
Volkonskiĭ VA
Eksp Onkol; 1990; 12(2):74-6. PubMed ID: 2318139
[TBL] [Abstract][Full Text] [Related]
16. Production of cachexia mediators by Walker 256 cells from ascitic tumors.
Rebeca R; Bracht L; Noleto GR; Martinez GR; Cadena SM; Carnieri EG; Rocha ME; de Oliveira MB
Cell Biochem Funct; 2008 Aug; 26(6):731-8. PubMed ID: 18646274
[TBL] [Abstract][Full Text] [Related]
17. [Circadian chronotherapy for Walker-256 of Wistar rat].
Sato T
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2287-90. PubMed ID: 7944461
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of nucleic acids and total proteins in thymus of Walker carcinosarcoma bearing rats.
Toma V; Giurgea R
Arch Geschwulstforsch; 1976; 46(4):271-5. PubMed ID: 1086083
[TBL] [Abstract][Full Text] [Related]
19. [Metabolic study of sarcoma 45 and Walker carcinosarcoma cells during growth and anticoagulant exposure. An autoradiographic study].
Kolomina SM; Pogodina LS; Chentsov IuS; Kudriashov BA; Vasil'eva TN
Tsitol Genet; 1982; 16(5):68-73. PubMed ID: 7147343
[TBL] [Abstract][Full Text] [Related]
20. [Change in the content of lipid-soluble antioxidants in animals with Walker-256 carcinosarcoma exposed to different therapies].
Patol Fiziol Eksp Ter; 2009; (3):27-9. PubMed ID: 19919013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
